Prospera Financial Services’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,125
Closed -$156K 2752
2022
Q1
$156K Buy
+4,125
New +$156K 0.01% 958